Is it time to buy Freedom Foods shares after today's update?

Is the Freedom Foods Group Ltd (ASX:FNP) share price in the buy zone after today's update?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In morning trade the Freedom Foods Group Ltd (ASX: FNP) share price has pushed higher following the release of an update on its nutritionals activities at its Shepparton site.

At the time of writing the diversified food company's shares are up slightly to $4.70.

What was in the update?

This morning the company advised that it has completed a key commissioning step in relation to Lactoferrin production at its new Nutritionals capability at Shepparton.

Lactoferrin is a protein found in both cow's milk and human milk. It plays a key role in the function of the immune system, helping to safeguard the body against bacterial, fungal, viral, and other pathogens.

Other benefits include promoting beneficial bacteria in the intestinal tract and regulating iron metabolism.

According to the release, the company has an initial installed capacity of 16 tonnes of Lactoferrin per annum. Based on progress through this important commissioning step, it expects sales of Lactoferrin to commence late in the fourth quarter FY 2019.

Pleasingly, Freedom Foods has advised that there has been a lot of interest in its Lactoferrin capacity and expects to sell its available capacity into FY 2020.

In addition to this, the company advised that its Micellar Casein production commenced in February and production of Native Whey Protein Isolate has now started. These proteins represent the purest, undiluted dairy protein source for use in high quality applications across infant, medical, sports, and weight management.

Interest has been high for both these products and the company expects the facility to move to full capacity during FY 2020.

All in all, management expects the Nutritionals segment to deliver a material earnings contribution in FY 2020.

In the first half of FY 2019 the Nutritionals segment was the company's smallest with revenue of $9.1 million. This equates to just 4.3% of the company's total half year revenue of $209 million.

But these developments are likely to bolster the segment's revenue greatly and make it a much bigger contributor in FY 2020.

Should you invest?

I think Freedom Foods is a quality company with significant long term growth potential.

This could make it worth considering along with industry peers A2 Milk Company Ltd (ASX: A2M) and Bellamy's Australia Ltd (ASX: BAL).

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. The Motley Fool Australia has recommended Bellamy's Australia and Freedom Foods Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Growth Shares

3 incredible ASX growth shares to buy and hold forever in 2026

True long-term investing means owning businesses you’d be happy to hold through volatility, uncertainty, and decades of change.

Read more »

Happy work colleagues give each other a fist pump.
Growth Shares

2 shares to buy hand over fist before the ASX 200 soars higher in 2026

These shares are highly rated by brokers for a reason. Here's what you need to know about them.

Read more »

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Broker Notes

Experts rate these 2 ASX shares as buys this month!

Leading analysts say these stocks are a buy.

Read more »

Happy healthcare workers in a labs
Technology Shares

Prediction: CSL shares could soar past $270 in 2026

Here's what to expect from the Australian-based global biotechnology company this year.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Growth Shares

2 unstoppable ASX 200 stocks to buy in 2026 and hold forever

These blue chips could have very bright futures. Do you own them?

Read more »

A man sees some good news on his phone and gives a little cheer.
Growth Shares

5 incredible ASX growth stocks to buy for 2026

These growth stocks could be well-positioned for the long-term.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Growth Shares

These 2 ASX growth shares are ideal for Australians!

These businesses could be much bigger in a decade!

Read more »

A couple cheers as they sit on their lounge looking at their laptop and reading about the rising Redbubble share price
Growth Shares

2 super ASX growth stocks to buy in bunches in 2026

If you’re looking for growth in 2026, these two ASX stocks are still very much in expansion mode.

Read more »